We are monitoring the impact of COVID-19 on Europe Nanomedicine Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6250
Share on
Share on

Europe Nanomedicine Market Research Report - Segmented By Product, By Disease Type, By Nanomolecule Type & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: February, 2020
ID: 6250
Pages: 145

Europe Nanomedicine Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Nanomedicine Market is valued at USD 36.77 billion in 2019 and is projected to grow at a CAGR of 11.7%, to reach USD 63.94 billion by 2024 during the forecast period 2019-2024. 

The application of various techniques and instruments of nanotechnology in the field of medicine is known as Nanomedicine. It involves using nanoscale materials to diagnose diseases, drug delivery and other functions. Nanomedicine has the potential to revolutionize medicine in the future.

One of the major challenges for the use of nanoparticles in medicine is to make the materials as biocompatible. Applications of nanocapsules in drug delivery have shown excellent results in chemotherapy. Nanomedicine enables great precision in both diagnostics and therapeutics which is not possible before. Pipeline products which are being developed with the intention to target cancerous tumors are expected to boost the nanomedicine market.

Increasing applications of nanomaterials such as nanocapsules and nanotubes in drug delivery systems, growing number of cancer and cardiovascular diseases, increasing public and private investments on research activities in nanomedicine and advancements in the biodegradable nanoparticles are the major factors propelling the growth of nanomedicine market. However, unfavorable approval processes possibility for unintended risks during therapies and high cost of treatment using nanomedicine are hindering the market growth.

This research report segmented and sub-segmented into the following categories:

  • By Product: Diagnostic Imaging, Regenerative Medicine, Drug Delivery, Implants, Vaccines And Others
  • By Disease Type: Cardiovascular Diseases, Neurological Diseases, Ophthalmological Diseases, Infectious Diseases, Immunological Diseases, Orthopedic Disorders, Oncological Diseases And Others
  • By Nanomolecule Type: Nanotubes, Nanoparticles, Nanodevices, Nanoshells And Others
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Europe is home for several major companies operating in nanomedicine which resulted in high market penetration and high awareness among people. United Kingdom leads the nanomedicine market in Europe. .

Key players operating in the Europe Nanomedicine Market profiled in this report are Johnson & Johnson, Merck & Co, Pfizer, Abbott Laboratories, GE Healthcare, Celgene Corporation, Nanosphere, Inc, Gilead Sciences, Hoffmann-La Roche, Nanospectra Biosciences, and Arrowhead Pharmaceuticals.

1. Introduction           

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods    

                1.4 General Study Assumptions  

2. Research Methodology                     

                2.1 Introduction         

                2.2 Research Phases

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design   

                2.4 Study Timeline    

3. Overview                 

                3.1 Executive Summary  

                3.2 Key Inferences   

                3.3 Epidemology        

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)              

                4.1 Market Drivers    

                4.2 Market Restraints      

                4.3 Key Challenges   

                4.4 Current Opportunities in the Market        

5. Market Segmentation                        

                5.1 Product  

                                5.1.1 Introduction                                           

                                5.1.2 Diagnostic Imaging 

                                5.1.3 Regenerative Medicine                                     

                                5.1.4 Drug Delivery                                         

                                5.1.5 Implants                                   

                                5.1.6 Vaccines                                   

                                5.1.7 Others                                      

                                5.1.8  Y-o-Y Growth Analysis, By Product                                              

                                5.1.9  Market Attractiveness Analysis, By Product                                            

                                5.1.10  Market Share Analysis, By Product                                            

                5.2 Disease Type       

                                5.2.1 Introduction                                           

                                5.2.2 Cardiovascular Diseases                                    

                                5.2.3 Neurological Diseases                                        

                                5.2.4 Ophthalmological Diseases

                                5.2.5 Infectious Diseases                                             

                                5.2.6 Immunological Diseases                                    

                                5.2.7 Orthopedic Disorders                                         

                                5.2.8 Oncological Diseases                                           

                                5.2.9 Others                                      

                                5.2.10 Y-o-Y Growth Analysis, By Disease Type                                  

                                5.2.11 Market Attractiveness Analysis, By Disease Type                                                

                                5.2.12 Market Share Analysis, By Disease Type                                  

                5.3 Nanomolecule Type         

                                5.3.1 Introduction                                           

                                5.3.2 Nanotubes

                                5.3.3 Nanoparticles                                        

                                5.3.4 Nanodevices                                          

                                5.3.5 Nanoshells

                                5.3.6 Others                                      

                                5.3.7 Y-o-Y Growth Analysis, By Nanomolecule Type                                       

                                5.3.8  Market Attractiveness Analysis, By Nanomolecule Type                                    

                                5.3.9  Market Share Analysis, By Nanomolecule Type                                     

6. Geographical Analysis                        

                6.1 Introduction         

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

  6.1.3.1 By Geographical Area                     

  6.1.3.2 By Product                           

  6.1.3.3 By Disease Type                

  6.1.3.4 By Nanomolecule Type                  

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Product                           

                                                6.1.4.3 By Disease Type                

  6.1.4.4 By Nanomolecule Type                  

                                6.1.5  Market Share Analysis                                      

  6.1.5.1 By Geographical Area                     

  6.1.5.2 By Product                           

  6.1.5.3 By Disease Type                

  6.1.5.4 By Nanomolecule Type                  

                6.2 U.K   

                6.3 Spain       

                6.4 Germany       

                6.5 Italy         

                6.6 France    

7. Strategic Analysis                 

                7.1 PESTLE analysis   

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis        

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                  

                8.1 Johnson & Johnson   

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Merck & Co  

                8.3 Pfizer      

                8.4 Abbott Laboratories         

                8.5 GE Healthcare     

                8.6 Celgene Corporation        

                8.7 Nanosphere, Inc

                8.8 Gilead Sciences   

                8.9 Hoffmann-La Roche  

                8.10 Nanospectra Biosciences     

                8.11 Arrowhead Pharmaceuticals       

9. Competitive Landscape                     

                9.1 Market share analysis      

                9.2 Merger and Acquisition Analysis 

                9.3 Agreements, collaborations and Joint Ventures   

                9.4 New Product Launches   

10. Market Outlook and Investment Opportunities                   

Appendix                     

                a) List of Tables  

                b) List of Figures        

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product Type, by Disease type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Europe Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  2. Europe Diagnostic Imaging Market By Region, From 2019-2024 ( USD Billion )
  3. Europe Regenerative Medicine Market By Region, From 2019-2024 ( USD Billion )
  4. Europe Drug Delivery Market By Region, From 2019-2024 ( USD Billion )
  5. Europe Implants Market By Region, From 2019-2024 ( USD Billion )
  6. Europe Vaccines Market By Region, From 2019-2024 ( USD Billion )
  7. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  8. Europe Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  9. Europe Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Billion )
  10. Europe Neurological Diseases Market By Region, From 2019-2024 ( USD Billion )
  11. Europe Ophthalmological Diseases Market By Region, From 2019-2024 ( USD Billion )
  12. Europe Infectious Diseases Market By Region, From 2019-2024 ( USD Billion )
  13. Europe Immunological Diseases Market By Region, From 2019-2024 ( USD Billion )
  14. Europe Orthopedic Disorders Market By Region, From 2019-2024 ( USD Billion )
  15. Europe Oncological Diseases Market By Region, From 2019-2024 ( USD Billion )
  16. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  17. Europe Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  18. Europe Nanotubes Market By Region, From 2019-2024 ( USD Billion )
  19. Europe Nanoparticles Market By Region, From 2019-2024 ( USD Billion )
  20. Europe Nanodevices Market By Region, From 2019-2024 ( USD Billion )
  21. Europe Nanoshells  Market By Region, From 2019-2024 ( USD Billion )
  22. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  23. U.K. Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  24. U.K. Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  25. U.K. Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  26. Germany Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  27. Germany Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  28. Germany Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  29. France Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  30. France Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  31. France Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  32. Italy Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  33. Italy Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  34. Italy Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  35. Spain Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  36. Spain Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  37. Spain Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample